EXPLAINER: Will AI Cure All Disease?

Will AI cure all disease? 90% of biomedical papers published in December 2025 show signs of AI assistance — and the Nobel laureate behind AlphaFold says AI could help end all disease within a decade. In this episode, Robert Lufkin MD examines what artificial intelligence is really doing to health science: the quiet takeover of the scientific paper, the first AI-discovered drug to pass a Phase 2a trial, robot laboratories running experiments around the clock, and the honest caveats behind the "end of disease" headlines — plus what it all means for your health today. **Chapters:** - 00:00 — The 90% Stat: AI Fingerprints in Biomedical Papers - 00:49 — Part 1: The Quiet Takeover of the Scientific Paper - 02:16 — Part 2: The Wins Are Real - 02:46 — AlphaFold, 200 Million Proteins & the 2024 Nobel Prize - 03:13 — Rentosertib: First AI-Discovered Drug to Pass Phase 2a - 04:02 — The Superbug Puzzle: 10 Years vs 2 Days - 04:22 — Part 3: Robot Labs & the 10-Year Promise - 05:26 — Demis Hassabis on "The End of Disease" - 06:26 — Part 4: The New Bottleneck Is Verification - 07:43 — Part 5: The Honest Caveats - 08:42 — Part 6: The Takeaway **Key takeaways:** - Roughly 90% of biomedical papers published in December 2025 show measurable signs of AI writing assistance — most of it polishing, not fraud. - AlphaFold predicted structures for essentially all 200 million known proteins and earned the 2024 Nobel Prize in Chemistry. - Rentosertib became the first drug with an AI-discovered target and AI-designed molecule to improve lung function in a randomized, placebo-controlled Phase 2a trial (Nature Medicine). - Autonomous "robot labs" like Lila Sciences ($1.3B valuation, backed by Nvidia) aim to run science at machine speed. - The bottleneck in science is shifting from producing findings to verifying them — zero AI-discovered drugs have full FDA approval so far. - No matter how fast discovery gets, your metabolic health remains the foundation AI can't replace. **Studies & sources:** - Kobak et al. — Detecting AI fingerprints in biomedical abstracts (preprint) - Nature News — AI-written biomedical literature - Nobel Prize in Chemistry 2024 — AlphaFold - Rentosertib Phase 2a randomized trial, Nature Medicine 2025 - BBC News — Imperial College superbug question answered by AI in 2 days - Fierce Biotech — Lila Sciences autonomous AI research labs - Lila Sciences — $1.3B valuation with Nvidia backing - CBS 60 Minutes — Demis Hassabis on "the end of disease" 📖 Dr. Lufkin's book "Lies I Taught in Medical School" > **⭐ Enjoying the show? Please leave a 5-star review on** Apple Podcasts **— it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!** New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/